Your browser doesn't support javascript.
The management of upper airway diseases: an ongoing challenge for the clinician.
Ciprandi, G; Passali, D.
  • Ciprandi G; Consultant allergist, Clinic, Casa di Cura Villa Montallegro, Genoa, Italy.
  • Passali D; International Federation ORL Societies (IFOS) Executive Board members, Rome, Italy.
J Biol Regul Homeost Agents ; 35(1 Suppl. 2): 1-2, 2021.
Article in English | MEDLINE | ID: covidwho-1227256
ABSTRACT
Upper airway diseases are widespread in clinical practice. However, some aspects are still debated. The current supplement presents and discusses the most common disorders encountered in daily medical activity. The COVID-19 dramatic pandemic requires an urgent solution. Promising non-pharmacological agents are discussed. Chronic diseases are frequent in childhood, so to know risk factors is useful in their management. Allergic rhinitis and chronic rhinosinusitis should be treated with anti-inflammatory drugs, but complementary compounds should be alternated to preserve health. Empty nose syndrome is a frequent complication of nasal surgery and requires adequate staging and hydrating procedure. Lastly, laryngopharyngeal reflux is an intriguing challenge for the clinician. Alginates represent a safe and effective way to relieve LPR symptoms.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Sinusitis / Rhinitis / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: J Biol Regul Homeost Agents Journal subject: Biology / Biochemistry Year: 2021 Document Type: Article Affiliation country: 21-1supp2-1

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Sinusitis / Rhinitis / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: J Biol Regul Homeost Agents Journal subject: Biology / Biochemistry Year: 2021 Document Type: Article Affiliation country: 21-1supp2-1